Silverarc Capital Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-104,828
Closed -$85K 117
2021
Q2
$85K Buy
104,828
+6,072
+6% +$4.35K 0.04% 93
2021
Q1
$93K Hold
98,756
0.05% 90
2020
Q4
$49K Buy
+98,756
New +$74.7K 0.03% 83

Silverarc Capital Management's CHAQ.WS Position: Q3 2021 in Review

Silverarc Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 104,828 shares — an estimated $85K sold.

Silverarc Capital Management first reported a position in CHAQ.WS in Q4 2020 and held it in 3 quarters. The position peaked at $93K in Q1 2021. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

  • Silverarc Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
  • Silverarc Capital Management sold 104,828 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $85K.
  • Silverarc Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q4 2020 and held it in 3 quarters.
  • Silverarc Capital Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $93K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Silverarc Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.